Vanderbilt University
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1873-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vanderbilt.edu
Omentectomy for the Treatment of Diabetes Mellitus Type 2
Phase 1
Completed
- Conditions
- Diabetes Mellitus Type 2DyslipidemiaHypercholesterolemiaObesity
- Interventions
- Procedure: removal of omentum
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2009-09-14
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 10
- Registration Number
- NCT00270439
- Locations
- ๐บ๐ธ
Vanderbilt University, Nashville, Tennessee, United States
Timing of Target Enteral Feeding in the Mechanically Ventilated Patient
Phase 2
Completed
- Conditions
- Acute Respiratory Failure
- Interventions
- Behavioral: trophic enteral feeds
- First Posted Date
- 2005-11-11
- Last Posted Date
- 2013-12-17
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 200
- Registration Number
- NCT00252616
- Locations
- ๐บ๐ธ
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients
Phase 2
Completed
- Conditions
- End Stage Renal Disease
- Interventions
- Dietary Supplement: nutritional supplementDrug: recombinant human growth hormone (rcGH)Behavioral: exercise
- First Posted Date
- 2005-10-25
- Last Posted Date
- 2015-05-25
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 46
- Registration Number
- NCT00244075
- Locations
- ๐บ๐ธ
Vanderbilt University, Nashville, Tennessee, United States
Provision of Antioxidant Therapy in Hemodialysis (PATH) Study
Phase 2
Completed
- Conditions
- End-stage Renal Disease
- Interventions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2012-01-11
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 385
- Registration Number
- NCT00237718
- Locations
- ๐บ๐ธ
Fresenius Medical Care North America, Nashville, Tennessee, United States
The Clinical Informationist: Does the Model Work
Not Applicable
Completed
- Conditions
- Critical Illness
- Interventions
- Other: Synthesized evidence report
- First Posted Date
- 2005-09-26
- Last Posted Date
- 2014-05-28
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 299
- Registration Number
- NCT00226291
- Locations
- ๐บ๐ธ
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Treatment of Supine Hypertension in Autonomic Failure
Phase 1
Completed
- Conditions
- Hypertension
- Interventions
- Drug: PlaceboDietary Supplement: L-arginineOther: Head-up tilt.Other: Local heat stress
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2017-10-13
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 152
- Registration Number
- NCT00223717
- Locations
- ๐บ๐ธ
Vanderbilt University, Nashville, Tennessee, United States
Treatment of Orthostatic Hypotension in Autonomic Failure
Phase 1
Completed
- Conditions
- Autonomic FailureOrthostatic Hypotension
- Interventions
- Drug: placeboDevice: inflatable abdominal binder (sham)Other: water intakeDietary Supplement: BovrilDevice: Inflatable abdominal binder
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 389
- Registration Number
- NCT00223691
- Locations
- ๐บ๐ธ
Vanderbilt University, Nashville, Tennessee, United States
Bradykinin Receptor Antagonism During Cardiopulmonary Bypass
Phase 2
Completed
- Conditions
- FibrinolysisCardiopulmonary BypassInflammationSurgery
- Interventions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 150
- Registration Number
- NCT00223704
- Locations
- ๐บ๐ธ
TN Valley Healthcare System, Nashville, Tennessee, United States
๐บ๐ธVanderbilt University, Nashville, Tennessee, United States
Chemotherapy Toxicity Reduction Via Urea Cycle Support
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 100
- Registration Number
- NCT00223730
- Locations
- ๐บ๐ธ
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Selenium Supplementation of Patients With Cirrhosis
Not Applicable
Completed
- Conditions
- HealthyLiver Cirrhosis
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-03-07
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 48
- Registration Number
- NCT00212186
- Locations
- ๐บ๐ธ
Vanderbilt University Medical Center, Nashville, Tennessee, United States